Unenhanced versus Spio-enhanced MRI in the evaluation of focal liver lesions;Studio delle lesioni focali epatiche. Confronto tra risonanza magnetica in condizioni di base e dopo mezzo di contrasto superparamagnetico

Radiologia Medica

Volumn 95, Issue 6, 1998, Pages 599-607

  Finazzo, Mario ^a   Midiri, Massimo ^a,b   Gallo, Cristina ^a   Bartolotta, Tommaso Vincenzo ^a   Luca, Angelo ^a  

^a Istituto di Radiologia P Cignolini   (Italy)

^b NONE   (Italy)

Author keywords

Focal liver lesions, MRI; Focal liver lesions, supermagnetic iron oxide; Liver, focal lesions

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER HEMANGIOMA; LIVER HYPERPLASIA; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; AGED; CARCINOMA; CONTRAST MEDIA; DRUG EVALUATION; FEMALE; FERROSOFERRIC OXIDE; HUMANS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES;

EID: 0031773149     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ameriks JA, Thompson NW, Frey CF e Coll: Hepatic cell adenomas, spontaneous liver rupture, and oral contraceptives. Arch Surg 110. 548-557, 1975.
2. Blakeborough A, Ward J, Wilson D e Coll. Hepatic lesion detection at MR Imaging: a comparative study with four sequences. Radiology 203: 759-765, 1997
3. Bruel JM: Endorem in detection of hepatic lesions with MR imaging, results of phase III trial Spotlight on Clinical MRI- Guerbet: 97-105, Maffliers VLC, 1996.
4. Caudana R, Morana O, Pirovano GP e Coll Focal malignant hepatic lesions MR imaging enhanced with Gd BOPTA-Preliminary resuls of phase II clinical application. Radiology 199: 513, 1996.
5. Denys A, Arrive L, Servois V e Coll: Hepatic tumors, detection and characterization at 1 T MR imaging enhanced with AMI 25. Radiology 193: 665-669, 1994.
6. Duda SH, Laniado M, Kopp AF e Coll: Superparamagnetic iron oxide, detection of focal liver lesions at high field strength MR Imaging J Magn Reson Imaging 4: 309-314, 1994.
7. Feltnn GP, Savastano S, Marangon A e Coll: Risultati a longo termine della chemioembolizzazione nell'epatocarcinoma. Radiol Med 94 24-29, 1997
8. Giovagnom A, Paci E, Valeri G e Coll: Fegato: RM tradizionale Radiol Med 91(Suppl 1 al n 5): 122-129, 1996
9. Grandin C, Van Beers BE. Robert A e Coll: Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration JCAT 19: 412-418, 1995
10. Grangier C, Tourniaire J, Mehta G e Coll. Enhancement of liver hemangiomas on T1 weighted MR SE Images by superparamagnetic iron oxide particles JCAT 18: 888-896, 1994
11. Hagspiel KD, Neidl KWF. Echenberger AC e Coll: Detection of liver metastases comparison of superparamagnetic iron oxide-enhanced and unenhanced MR Imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 196 471-478, 1995
12. Hamm B, Staks T, Taupitz M e Coll. Contrast enhanced MR imaging of liver and spleen first experience in humans with a new superparamagnetic iron oxide. J Magn Reson Imaging 4. 659-668, 1994
13. Harakate J, Scheuer PJ: An immunohistochemical and ultrastructural study of the sinusoids of hepatocellular carcinoma Cancer 65: 1985-1993, 1990
14. Ichida T, Hata K, Yamada S e Coll: Subcellular abnormalities of liver sinusoidal lesions in human hepatocellular carcinoma. J Submicrosc Cytol Pathol 22 221-229, 1990
15. Ito K, Honjo K, Fujita T e Coll: Liver neoplasms diagnostic pitfalls in crosssectional imaging RadioGraphics 16. 273-293, 1996.
16. Josephson L, Lewis J, Jacobs P e Coll: The effect of iron oxides on proton relaxivity Magn Reson Imag 6 647-653, 1988.
17. Kane PA, Ayton V, Walters HL e Coll: Mn DPDP enhanced MR imaging of the liver correlation with sursical findings Acta Radiol 38. 650-654, 1997
18. Kressel HY, Abbas YA: The liver and pancreas. In: Higgins CB, HricaK H, Helms CA (eds) Magnetic Resonance Imaging of the body, pag 721-760, Raven Press. NY 1992
19. Lencioni R, Paolicchi A, Bartulozzi C Alcolizzazione peicutanea dell' epatocarcinoma: risultati a lungo termine. Radiol Med 94: 8-13, 1997
20. Mahfouz AE, Hamm B, Taupitz M: Contrast agents for MR imaging of the liver a clinical overview. Eur Radiol 7: 507-513, 1997.
21. Manfredi R. Maresca G, De Gaetano AM e Coll: La caratterizzazione tissutale delle lesioni focali epatiche con Risonanza Magnetica Radiol Med 90: 250-261, 1995.
22. Olivetti L, Grazioli L, Maroldi R e Coll. Studio dinamico con Risonanza Magnetica delle lesioni focali epatiche mediante sequenze Flash con endovena a bolo. Radiol Med 83: 353-360, 1992
23. Oudkerk M, van den Heuvel AG, Wielopolski PA e Coll: Hepatic lesions: detection with ferumoxide-enhanced T1 weighted MR imaging. Radiology 203. 449-456, 1997
24. Pavone P, Di Girolamo M, Catalano C e Coll: Mezzi di contrasto. Radiol Med 91 (Suppl. 1 al n 5): 37-42, 1996.
25. Roubidoux MA: MR Imaging of hemorrhage and iron deposition in the kidney. RadioGraphics 14 1033-1044, 1994
26. Seneterre E, Taourel P, Bouvier Y e Coll: Detection of hepatic metastates. Ferumoxide-enhanced MR Imaging versus unhenanced MR imaging and CT during arterial portography Radiology 200 785, 1996.
27. Soyer P: Will ferumoxides-enhanced MR Imaging replace CT during arterial portography in the detection of hepatic metastates? Prologue to a promising future Radiology 201 610-611, 1996
28. Spinazzi A, Davies A, Villa A e Coll Stato attuale e prospettive future della ricerca di nuovi mezzi di contrasto. Radiol Med 91 (Suppl 1 al n. 5): 43-52, 1996.
29. Stark DD, Weissleder R, Elizondo G e Coll: Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver Radiology 168: 297-301, 1988.
30. Sugarbaker PH: Surgical decision making for large bowel cancer metastatic to the liver Radiology 174: 621, 1990.
31. Vogl TJ, Kummel S, Hammerstingl R e Coll: Liver tumors comparison of MR Imaging with Gd EOB DTPA and Gd DTPA. Radiology 200: 59-67, 1996.
32. Vogl TJ, Hammerstingl R, Schwarz W e Coll: Superparamagnetic iron oxide enhanced versus gadolinium enhanced MR Imaging for differential diagnosis of focal liver lesions. Radiology 198: 881, 1996.
33. Yamamoto H, Yamashita Y, Yoshimatsu S e Coll: Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR Imaging. Radiology 195 106-112, 1995
34. Villa A, Meloni G. Sammarchi L e Coll: Fegato, sequence Fast e Ultrafast. Radiol Med 91 (Suppl 1 al n. 5). 130-136, 1996.
35. Villa A, Moro G, Genovese E e Coll: Studio sequenziale dinamico delle lesiom focali epatiche mediante sequenze ultrafast e impiego di Gadolinio-DTPA in bolo rapide. Radiol Med 85. 352-363, 1993.